-
Jan 18, 2025 | 
mdpi.com | Hao Luo |Xinyue Wang |Li Zhang
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jan 11, 2025 | 
mdpi.com | Xinyue Wang |Tong Ma |Zhiyuan Chen |Yang Liu
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Nov 13, 2024 | 
nature.com | Xinyue Wang |William J Jowsey |Boatema Ofori-Anyinam |Nicholas West |Jason Yang |Peter C. Fineran | +3 more
AbstractDrug-resistant strains of Mycobacterium tuberculosis are a major global health problem. Resistance to the front-line antibiotic isoniazid is often associated with mutations in the katG-encoded bifunctional catalase-peroxidase. We hypothesise that perturbed KatG activity would generate collateral vulnerabilities in isoniazid-resistant katG mutants, providing potential pathway targets to combat isoniazid resistance.
-
Oct 16, 2024 | 
mdpi.com | Wenzhe Li |Xinyue Wang |Yanqing Jiang |Shuning Cui
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Sep 2, 2024 | 
nature.com | Jing Zhou |Xinyue Wang
AbstractAcquired resistance is inevitable in the treatment of non-small cell lung cancer (NSCLC) with osimertinib, and one of the primary mechanisms responsible for this resistance is the epithelial-mesenchymal transition (EMT). We identify upregulation of the proviral integration site for Moloney murine leukemia virus 1 (PIM1) and functional inactivation of glycogen synthase kinase 3β (GSK3β) as drivers of EMT-associated osimertinib resistance.
-
Aug 23, 2024 | 
mdpi.com | Xinyue Wang |Yang Liu |Zhiyuan Chen |Kexin Wang
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Aug 9, 2024 | 
press.accor.com | Xinyue Wang
Accor, a Premium Partner of the Paris 2024 Olympic and Paralympic Games, is proud to have enabled Kauli to fulfil his dream of surfing on the Seine against the backdrop of the Eiffel Tower, and that is how he celebrated winning gold on Tahiti’s legendary Teahupo’o wave with all the Olympic crowds in Paris. This Friday morning, at the end of the open water swimming marathon, Kauli Vaast set off to surf the Seine, gold medal around his neck.
-
Aug 3, 2024 | 
mdpi.com | Xinyue Wang |Ruoyu Hu |Chengqi Xue
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jul 30, 2024 | 
mdpi.com | Xinyue Wang |Yaxin Li |Chengqi Xue
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jun 5, 2024 | 
press.accor.com | Xinyue Wang
ABOUT ACCORAccor is a world leading hospitality group offering experiences across more than 110 countries, with 5,600 properties, 10,000 food & beverage venues, wellness facilities or flexible workspaces. The Group has one of the industry’s most diverse hospitality ecosystems, encompassing more than 45 hotel brands from luxury to economy, as well as Lifestyle with Ennismore.
